Trial Profile
MILESTONE-II
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2007
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms MILESTONE-II
- Sponsors Boston Scientific Corporation
- 11 Dec 2007 New trial record.